{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T09:07:06Z","timestamp":1784797626905,"version":"3.55.0"},"reference-count":42,"publisher":"National University of Health Sciences","issue":"4","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journalchiromed.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chiropractic Medicine"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.jcm.2016.08.003","type":"journal-article","created":{"date-parts":[[2016,10,8]],"date-time":"2016-10-08T23:30:21Z","timestamp":1475969421000},"page":"272-280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["A Review of the Centers for Disease Control and Prevention\u2019s Guidelines for the Clinical Laboratory Diagnosis of Lyme Disease"],"prefix":"10.67400","volume":"15","author":[{"given":"Caterina M.","family":"Miraglia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"57152","reference":[{"key":"10.1016\/j.jcm.2016.08.003_bb0005","series-title":"Two-step laboratory testing process","author":"Centers for Disease Control and Prevention","year":"2015"},{"issue":"31","key":"10.1016\/j.jcm.2016.08.003_bb0010","first-page":"590","article-title":"Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease","volume":"44","author":"Centers for Disease Control and Prevention","year":"1995","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.jcm.2016.08.003_bb0015","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/art.1780200102","article-title":"Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three Connecticut communities","volume":"20","author":"Steere","year":"1977","journal-title":"Arthritis Rheum"},{"issue":"4552","key":"10.1016\/j.jcm.2016.08.003_bb0020","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.7043737","article-title":"Lyme disease\u2014a tick-borne spirochetosis?","volume":"216","author":"Burgdorfer","year":"1982","journal-title":"Science"},{"issue":"SS10","key":"10.1016\/j.jcm.2016.08.003_bb0025","first-page":"1","article-title":"Surveillance for Lyme disease\u2014United States, 1992-2006","volume":"57","author":"Bacon","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jcm.2016.08.003_bb0030","series-title":"Lyme disease\u2014life cycle of blacklegged ticks","author":"Centers for Disease Control and Prevention","year":"2011"},{"issue":"2","key":"10.1016\/j.jcm.2016.08.003_bb0035","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM200107123450207","article-title":"Lyme disease","volume":"345","author":"Steere","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcm.2016.08.003_bb0040","series-title":"The Challenges of Lyme Disease: From Clinical Diagnosis to Testing Methodology","author":"Lewandrowski","year":"2015"},{"key":"10.1016\/j.jcm.2016.08.003_bb0045","series-title":"National Notifiable Diseases Surveillance System. Lyme disease (Borrelia burgdorferi) 2011 case definition","author":"Centers for Disease Control and Prevention","year":"2015"},{"issue":"9","key":"10.1016\/j.jcm.2016.08.003_bb0050","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the infectious diseases society of America","volume":"43","author":"Wormser","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcm.2016.08.003_bb0055","series-title":"Lyme disease clinical presentation\u2014physical examination","author":"Medscape","year":"2016"},{"key":"10.1016\/j.jcm.2016.08.003_bb0060","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1201\/b14120-46","article-title":"Neurologic manifestations of Lyme disease","volume":"68","author":"Lieberman","year":"2005","journal-title":"Neurol Dis Ther"},{"issue":"10","key":"10.1016\/j.jcm.2016.08.003_bb0065","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1002\/art.22131","article-title":"Therapy for Lyme arthritis: strategies for the treatment of antibiotic-refractory arthritis","volume":"54","author":"Steere","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jcm.2016.08.003_bb0070","series-title":"Lyme Disease: An Evidence-based Approach","first-page":"73","article-title":"Laboratory diagnostic testing for Borrelia burgdorferi infection","author":"Johnson","year":"2011"},{"key":"10.1016\/j.jcm.2016.08.003_bb0075","series-title":"Understanding the EIA test","author":"Centers for Disease Control and Prevention","year":"2015"},{"key":"10.1016\/j.jcm.2016.08.003_bb0080","series-title":"HHS federal research update on Lyme disease diagnostics activities","author":"Beard","year":"2012"},{"key":"10.1016\/j.jcm.2016.08.003_bb0085","series-title":"Lyme disease workup","author":"Medscape","year":"2015"},{"key":"10.1016\/j.jcm.2016.08.003_bb0090","series-title":"Immunetics C6 B. burgdorferi (Lyme) ELISA Kit [package insert]","year":"2013"},{"key":"10.1016\/j.jcm.2016.08.003_bb0095","series-title":"Understanding the immunoblot test","author":"Centers for Disease Control and Prevention","year":"2015"},{"issue":"2","key":"10.1016\/j.jcm.2016.08.003_bb0100","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/infdis\/167.2.392","article-title":"Western blotting in the serodiagnosis of Lyme disease","volume":"167","author":"Dressler","year":"1993","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jcm.2016.08.003_bb0105","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1128\/JCM.33.2.419-427.1995","article-title":"Immunoblot interpretation criteria for serodiagnosis of early Lyme disease","volume":"33","author":"Engstrom","year":"1995","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.jcm.2016.08.003_bb0110","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1471-2334-9-79","article-title":"Diagnostic challenges of early Lyme disease: lessons from a community case series","volume":"9","author":"Aucott","year":"2009","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.jcm.2016.08.003_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JCM.34.1.1-9.1996","article-title":"Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans","volume":"34","author":"Aguero-Rosenfeld","year":"1996","journal-title":"J Clin Microbiol"},{"issue":"15","key":"10.1016\/j.jcm.2016.08.003_bb0120","first-page":"333","article-title":"Concerns regarding a new culture method for Borrelia burgdorferi not approved for the diagnosis of Lyme disease","volume":"63","author":"Nelson","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"05","key":"10.1016\/j.jcm.2016.08.003_bb0125","first-page":"125","volume":"54","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jcm.2016.08.003_bb0130","series-title":"Other types of laboratory testing","author":"Centers for Disease Control and Prevention","year":"2015"},{"key":"10.1016\/j.jcm.2016.08.003_bb0135","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.7326\/0003-4819-127-12-199712150-00011","article-title":"Guidelines for laboratory evaluation in the diagnosis of Lyme disease","volume":"127","author":"Tugwell","year":"1997","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.jcm.2016.08.003_bb0140","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1128\/JCM.34.3.724-727.1996","article-title":"Immunoserologic evidence of coinfection with Borrelia burgdorferi, Babesia microti, and human granulocytic Ehrlichia species in residents of Wisconsin and Minnesota","volume":"34","author":"Mitchell","year":"1996","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcm.2016.08.003_bb0145","series-title":"Tickborne diseases of the United States\u2014anaplasmosis","author":"Centers for Disease Control and Prevention","year":"2014"},{"key":"10.1016\/j.jcm.2016.08.003_bb0150","series-title":"Tickborne diseases of the United States\u2014babesiosis","author":"Centers for Disease Control and Prevention","year":"2015"},{"key":"10.1016\/j.jcm.2016.08.003_bb0155","series-title":"National Notifiable Diseases Surveillance System. 2016 nationally notifiable conditions","author":"Centers for Disease Control and Prevention","year":"2016"},{"key":"10.1016\/j.jcm.2016.08.003_bb0160","series-title":"National Notifiable Diseases Surveillance System. Data collection and reporting","author":"Centers for Disease Control and Prevention","year":"2015"},{"key":"10.1016\/j.jcm.2016.08.003_bb0165","series-title":"Guide to surveillance, reporting, and control\u2014Lyme disease","author":"Massachusetts Department of Public Health Bureau of Infectious Disease","year":"2006"},{"key":"10.1016\/j.jcm.2016.08.003_bb0170","unstructured":"New York State Department of Health. Communicable disease reporting requirements. Albany, NY: New York State Department of Health. Available at: https:\/\/www.health.ny.gov\/forms\/instructions\/doh-389_instructions.pdf. Accessed April 13, 2016."},{"key":"10.1016\/j.jcm.2016.08.003_bb0175","series-title":"Rules and regulations pertaining to the reporting of infectious, environmental, and occupational diseases","author":"State of Rhode Island Department of Health","year":"2013"},{"key":"10.1016\/j.jcm.2016.08.003_bb0180","series-title":"Guide to surveillance, reporting, and control\u2014introduction","author":"Massachusetts Department of Public Health Bureau of Infectious Disease","year":"2014"},{"issue":"4","key":"10.1016\/j.jcm.2016.08.003_bb0185","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1469-0691.2011.03492.x","article-title":"The expanding Lyme Borrelia complex \u2013 clinical significance of genomic species?","volume":"17","author":"Stanek","year":"2011","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"10.1016\/j.jcm.2016.08.003_bb0190","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.3201\/eid1111.050542","article-title":"Borrelia spielmanii erythema migrans, Hungary","volume":"11","author":"F\u00f6ldv\u00e1ri","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jcm.2016.08.003_bb0195","doi-asserted-by":"crossref","first-page":"91","DOI":"10.7326\/M15-0333","article-title":"Borrelia miyamotoi disease in the Northeastern United States","volume":"163","author":"Molloy","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jcm.2016.08.003_bb0200","series-title":"Tiez fundamentals of clinical chemistry","first-page":"260","year":"2001"},{"issue":"6","key":"10.1016\/j.jcm.2016.08.003_bb0205","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/bjaceaccp\/mkn041","article-title":"Clinical tests: sensitivity and specificity","volume":"8","author":"Lalkhen","year":"2008","journal-title":"Contin Educ Anaesth Crit Care Pain"},{"key":"10.1016\/j.jcm.2016.08.003_bb0210","series-title":"Package Insert: B. burgdorferi (IgG) Marblot Strip Test System: Western Blot System for the Detection of IgG Antibody to Borrelia burgdorferi","year":"2014"}],"container-title":["Journal of Chiropractic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155637071630089X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155637071630089X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T08:49:47Z","timestamp":1784796587000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcm.kglmeridian.com\/doi\/10.1016\/j.jcm.2016.08.003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S155637071630089X"],"URL":"https:\/\/doi.org\/10.1016\/j.jcm.2016.08.003","relation":{},"ISSN":["1556-3707"],"issn-type":[{"value":"1556-3707","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Review of the Centers for Disease Control and Prevention\u2019s Guidelines for the Clinical Laboratory Diagnosis of Lyme Disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Chiropractic Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcm.2016.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}]}}